Mednet Logo

Are you incorporating ArteraAI for risk stratification and treatment for prostate cancer?

ArteraAI is now listed as level 1 by NCCN guidelines for evidence of validation as a risk stratification tool
Community PollStarted

Are you incorporating ArteraAI for risk stratification and treatment for prostate cancer?

94 physicians have voted

Join Mednetto vote and see how they answered.